Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares ...Middle East

PR Newswire - News
Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares
NEW HAVEN, Conn., March 15, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial–stage biopharmaceutical company with a marketed drug for the acute treatment of migraine and a portfolio of innovative, late–stage product candidates targeting...

Hence then, the article about biohaven announces pricing of 200 million public offering of common shares was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News